NCT00950807 - GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

September 1, 2009

Primary Completion Date

March 1, 2010

Study Completion Date

March 15, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium

long-acting muscarinic receptor antagonist; 18mcg once-daily

DRUG

Placebo

Inactive/ excipients only

DRUG

GSK573179

GSK573179 investigational drug

Trial Locations (19)

10787

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

20253

GSK Investigational Site, Hamburg

22927

GSK Investigational Site, Großhansdorf

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29379

GSK Investigational Site, Union

29615

GSK Investigational Site, Greenville

29640

GSK Investigational Site, Easley

29678

GSK Investigational Site, Seneca

30159

GSK Investigational Site, Hanover

39112

GSK Investigational Site, Magdeburg

45231

GSK Investigational Site, Cincinnati

55131

GSK Investigational Site, Mainz

60596

GSK Investigational Site, Frankfurt am Main

65187

GSK Investigational Site, Wiesbaden

85013

GSK Investigational Site, Phoenix

91786

GSK Investigational Site, Upland

92117

GSK Investigational Site, San Diego